Leveraging Biomaterial Platforms to Study Aging-Related Neural and Muscular Degeneration

Biomolecules. 2024 Jan 4;14(1):69. doi: 10.3390/biom14010069.

Abstract

Aging is a complex multifactorial process that results in tissue function impairment across the whole organism. One of the common consequences of this process is the loss of muscle mass and the associated decline in muscle function, known as sarcopenia. Aging also presents with an increased risk of developing other pathological conditions such as neurodegeneration. Muscular and neuronal degeneration cause mobility issues and cognitive impairment, hence having a major impact on the quality of life of the older population. The development of novel therapies that can ameliorate the effects of aging is currently hindered by our limited knowledge of the underlying mechanisms and the use of models that fail to recapitulate the structure and composition of the cell microenvironment. The emergence of bioengineering techniques based on the use of biomimetic materials and biofabrication methods has opened the possibility of generating 3D models of muscular and nervous tissues that better mimic the native extracellular matrix. These platforms are particularly advantageous for drug testing and mechanistic studies. In this review, we discuss the developments made in the creation of 3D models of aging-related neuronal and muscular degeneration and we provide a perspective on the future directions for the field.

Keywords: 3D muscular models; 3D neural models; aging; biomaterials.

Publication types

  • Review

MeSH terms

  • Biocompatible Materials / therapeutic use
  • Humans
  • Nerve Tissue*
  • Quality of Life
  • Sarcopenia* / therapy

Substances

  • Biocompatible Materials